alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc

Term ID

CHEBI:72318

Synonyms

5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->6)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
alpha-Neu5Ac-(2->6)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc
N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-D-glucosamine
Neu5Aca2-6GlcNAcb1-4GlcNAcb1-4GlcNAc
Neu5Acalpha2-6GlcNAcbeta1-4GlcNAcbeta1-4GlcNAc

Definition

An amino tetrasaccharide comprising an α-sialyl residue, two N-acetyl-β-D-glucosaminyl residues and an N-acetyl-D-glucosamine residue linked in a (2→6), (1→4) and (1→4) sequence.

References

pubmed:19443021
pubmed:31537530

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc

Phenotype where environments contain alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc

Phenotype modified by environments containing alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc

Phenotype affecting alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc

Human Disease Model